Christopher Smith

Christopher Smith is a highly experienced Principal Scientist at Nvelop Therapeutics, specializing in method development for biochemical and biophysical characterization of gene therapy modalities since November 2023. Prior to this role, Christopher served as a Senior Scientist in Analytical Development at Oxford Biomedica, focusing on AAV capsid analysis, and held several positions at Homology Medicines, Inc., where expertise in analytical methods for AAV variants was developed. Christopher's background also includes analytical work at AbbVie, protein research at Enzo Life Sciences, and postdoctoral research at Northern Illinois University, complemented by a Ph.D. in Biochemistry and a Bachelor's degree in Biology from prestigious institutions.